MWM
ICCC icon

Mission Wealth Management’s ImmuCell ICCC Stock Holding History

Mission Wealth Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,000
Closed -$50.9K – 690
2023
Q4 		$50.9K Hold
10,000
– – ﹤0.01% 576
2023
Q3 		$53.4K Buy
+10,000
New +$50.7K ﹤0.01% 539

Other funds holding ICCC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Mission Wealth Management's ICCC Position: Q1 2024 in Review

Mission Wealth Management sold out of ImmuCell (ICCC) in Q1 2024, closing a stake of 10,000 shares — an estimated $50.9K sold.

Mission Wealth Management first reported a position in ICCC in Q3 2023 and held it in 2 quarters. The position peaked at $53.4K in Q3 2023. 25 funds tracked by Wall St. Rank hold ICCC as of Q1 2024.

  • Mission Wealth Management reported no remaining ImmuCell position as of Q1 2024 after selling out during the quarter.
  • Mission Wealth Management sold 10,000 ImmuCell shares in Q1 2024, an estimated $50.9K.
  • Mission Wealth Management first reported a position in ImmuCell in Q3 2023 and held it in 2 quarters.
  • Mission Wealth Management's ImmuCell position peaked at $53.4K in Q3 2023.
  • 25 funds tracked by Wall St. Rank held ImmuCell as of Q1 2024.

Based on Mission Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.